SanderFlormanMD

General Surgery • New York, NY

Transplantation

Professor, Surgery, Icahn School of Medicine at Mount Sinai

Join to view full profile

Dr. Florman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Florman's full profile

Already have an account?

Office
5 E 98th St
12th Flr
New York, NY 10029
Phone+1 212-241-6591

Education & Training

Tulane UniversityResidency, Surgery, 1994 - 2000
University of Louisville School of MedicineClass of 1994

Certifications & Licensure

NY State Medical License 1996 - 2026
LA State Medical License 1995 - 2010
American Board of Surgery Surgery

Awards, Honors, & Recognition

Super Doctor SuperDoctors.com
Fellow American College of Surgeons

Clinical Trials

Study of Hepatitis C Virus (HCV) Entry Inhibitor in Liver Transplant Recipients With HCV Infection Start of enrollment: 2012 Mar 01
Terminated
Phase 1
Assessment of Intrahepatic Hepatitis C Virus (HCV) RNA Levels at the Time of Liver Transplantation Start of enrollment: 2013 Jun 01
Unknown status
Early Conversion From CNI to Belatacept in Renal Transplant Recipients With Delayed and Slow Graft Function Start of enrollment: 2013 Jun 01
Unknown status
Phase 2
Eculizumab for Prevention of Delayed Graft Function (DGF) in Kidney Transplantation Start of enrollment: 2013 Aug 01
Terminated
Phase 2
OCS Liver PROTECT Continued Access Protocol Start of enrollment: 2020 Feb 03
COMPLETED
NA
OCS Liver DCD Trial Start of enrollment: 2020 Jul 24
TERMINATED
NA
Observational Study of HIV+ Deceased Donor Transplant for HIV+ Recipients
RECRUITING
Roles: Principal Investigator, Contact
HOPE in Action Trial of HIV+ Deceased Donor Liver Transplants for HIV+ Recipients Start of enrollment: 2019 Jan 04
Active, not recruiting
Not Applicable
Roles: Principal Investigator, Contact
Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney) Start of enrollment: 2024 May 22
Recruiting
Not Applicable
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

A prospective multicenter validation of RETREAT for post-transplantation hepatocellular carcinoma recurrence prediction.
P Jonathan Li, Parissa Tabrizian, Darine Daher, Felipe Gaviria, Veeral Ajmera
Hepatology. 2025-03-11
7 citations
Intention-to-treat outcomes of patients with hepatocellular carcinoma receiving immunotherapy before liver transplant: The multicenter VITALITY study.
Parissa Tabrizian, Matthew L Holzner, Veeral Ajmera, Amy K Kim, Kali Zhou
Journal of Hepatology. 2025-03-01
Normothermic machine perfusion of explanted livers: Exploratory study of an alternative translational model for end-stage liver disease.
Rachel Todd, L Leonie van Leeuwen, Matthew Holzner, Leona Kim-Schluger, Maria Isabel Fiel
Artificial Organs. 2025-03-01

Journal Articles

Organs from Deceased Donors with False‐Positive HIV Screening Tests: An Unexpected Benefit of the HOPE Act
Shirish Huprikar, Sander Florman, Shikha G Mehta, American journal of transplantation

Press Mentions

Kidney Transplantation Between Those with HIV Infections Shown Safe & EffectiveOctober 17th, 2024
Ten Medical and Scientific Breakthroughs of 2021 at Mount SinaiDecember 28th, 2021
What Mount Sinai’s Trachea Transplant Success Means for Patients in NeedApril 9th, 2021
Join now to see all